Interview Questions for Biosecurity Audits

My experience in conducting biosecurity audits spans over ten years, encompassing a wide range of facilities, from high-containment laboratories handling select agents to agricultural settings and pharmaceutical manufacturing plants. I’ve led audits for both national and international organizations, employing various methodologies including self-assessments, desk audits, and on-site inspections. A recent project involved a comprehensive biosecurity audit of a large-scale agricultural facility, where we identified vulnerabilities in their pest management protocols and developed corrective action plans to mitigate the risk of pathogen introduction and spread. Another significant project involved assessing the biosecurity posture of a research institution handling genetically modified organisms, resulting in improvements in their access control and waste disposal procedures.

My approach is always collaborative, focusing not just on identifying weaknesses but also on empowering stakeholders to implement robust solutions. I’m skilled in translating complex biosecurity concepts into clear, actionable recommendations, and I ensure that the audit process is respectful and sensitive to the operations of the audited organization.

A comprehensive biosecurity risk assessment involves a systematic process of identifying, analyzing, and prioritizing potential threats and vulnerabilities impacting the security of biological materials. It’s like a detective story, where we investigate all possible scenarios that could compromise safety. This process typically includes:

• Threat Identification: Identifying potential threats, such as accidental release, theft, deliberate misuse, or natural disasters.
• Vulnerability Assessment: Pinpointing weaknesses in existing biosecurity systems, like inadequate access controls, compromised physical security, or gaps in staff training.
• Risk Analysis: Evaluating the likelihood and potential impact of each identified threat and vulnerability using a risk matrix. This helps prioritize which threats pose the greatest danger.
• Risk Mitigation: Developing and implementing strategies to reduce or eliminate the identified risks, such as improving physical security measures, enhancing staff training, or implementing emergency response plans.
• Monitoring and Evaluation: Regularly assessing the effectiveness of the implemented mitigation strategies and making adjustments as needed.

For example, in a laboratory setting, a risk assessment might identify the theft of a pathogenic organism as a threat and inadequate access control as a vulnerability. The risk analysis would then quantify the likelihood and potential impact of such a theft. Mitigation strategies could include installing advanced security systems, implementing stricter access protocols, and improving staff training on security procedures.

I’m familiar with a range of international biosecurity standards and frameworks. Key among these are:

• World Organisation for Animal Health (OIE): Their standards focus on animal health and preventing the spread of animal diseases internationally. Their guidelines are crucial for agricultural biosecurity and trade.
• Food and Agriculture Organization of the United Nations (FAO): Provides guidelines on plant health and the prevention of the spread of plant pests and diseases. This is crucial for crop protection and food security.
• World Health Organization (WHO): Sets standards for human health, particularly for the prevention and control of infectious diseases. They address issues related to emerging infectious diseases and pandemic preparedness.
• Biosafety Level (BSL) guidelines: These guidelines provide a framework for containment levels in laboratories dealing with various risk groups of biological agents. The system progresses from BSL-1 (low risk) to BSL-4 (highest risk).

Understanding these frameworks is essential for ensuring compliance and implementing internationally recognized best practices in biosecurity.

Identifying and assessing vulnerabilities in a biosecurity system is a multi-faceted process that requires a thorough understanding of the system’s components and potential weaknesses. I use a combination of methods, including:

• Gap analysis: Comparing the existing biosecurity system against established best practices and standards (like those mentioned above) to identify discrepancies and potential loopholes.
• Vulnerability scans: Employing technical tools to assess the security of IT systems and network infrastructure associated with biological data and control systems.
• Interviews and surveys: Gathering information from personnel at various levels to gain insights into their understanding of biosecurity protocols, identify areas of confusion, or reveal potential weaknesses in the system.
• Observation: Direct observation of facilities, operations, and staff interactions can highlight potential security flaws not readily apparent through other methods. For example, observing how personnel handle biological materials or how access controls are implemented.
• Threat modeling: This involves systematically analyzing potential threats and their impact on the system to identify vulnerabilities that could be exploited.

For instance, during a recent audit, we identified a weakness in a laboratory’s access control system. Our gap analysis highlighted a lack of two-factor authentication. Further investigation revealed that personnel were circumventing certain security protocols, highlighting a training deficiency.

Verifying the effectiveness of biosecurity controls requires a combination of approaches to ensure the robustness of the overall system. This isn’t a one-size-fits-all solution; it’s adaptable to the specific context and system in question. My methods include:

• Testing and simulations: Conducting mock scenarios (e.g., simulated breaches or emergencies) to evaluate the effectiveness of response plans and the readiness of personnel.
• Compliance audits: Regular checks to ensure adherence to established procedures, policies, and regulatory requirements.
• Data analysis: Reviewing relevant data, such as incident reports, access logs, and maintenance records, to identify trends and potential weaknesses.
• Performance indicators: Tracking key performance indicators (KPIs) to measure the effectiveness of specific biosecurity measures over time. For example, the number of security incidents or the time taken to respond to an emergency.
• Independent verification: Engaging an external expert to review the findings and provide an independent assessment of the system’s effectiveness.

For example, we might simulate a theft scenario in a laboratory to test the effectiveness of security systems and response protocols. Analyzing access logs could reveal patterns of unauthorized access, highlighting potential vulnerabilities.

Biosecurity audit reporting and documentation are critical for ensuring transparency and accountability. My reports are meticulously documented and structured to be easily understood by both technical and non-technical audiences. The structure typically involves:

• Executive Summary: A concise overview of the audit scope, methodology, key findings, and recommendations.
• Methodology: A detailed description of the audit process, including the standards, frameworks, and tools used.
• Findings: A comprehensive list of identified vulnerabilities and risks, categorized by severity and impact.
• Recommendations: Specific, actionable steps to address identified vulnerabilities and improve biosecurity.
• Corrective Action Plan (CAP): A timeline for implementation of the recommended actions, including responsibilities and milestones. This is essential for tracking progress and ensuring accountability.
• Appendices: Supporting documentation, such as data analysis results, survey data, and interview transcripts.

I ensure all reports are well-organized, use clear language, and avoid technical jargon whenever possible. I always aim for collaboration, providing guidance and support to the audited organization throughout the process to ensure effective implementation of improvements.

Prioritizing biosecurity risks involves a systematic approach that considers both the likelihood and potential impact of each risk. A commonly used method is a risk matrix, which assigns a level of severity based on these two factors. I generally use a 3×3 matrix (Low, Medium, High for both likelihood and impact), resulting in nine severity levels. This matrix allows for a visual representation of the relative importance of each identified risk.

For example:

• High Likelihood, High Impact: This would represent a critical risk, requiring immediate attention and significant resources for mitigation. This might be a scenario like a major power failure in a high-containment laboratory.
• Low Likelihood, Low Impact: This would represent a minor risk that requires minimal attention. It could be something like a minor software glitch in a non-critical system.
• Medium Likelihood, High Impact: This is a serious risk that warrants significant mitigation efforts, even though it might not be as immediately pressing as a high-likelihood, high-impact risk. An example might be a lack of comprehensive emergency response training for personnel.

After assigning risk levels, prioritization can be done by focusing first on high-impact, high-likelihood risks, then moving down the matrix based on the overall severity. The use of risk scoring systems ensures objective assessment and provides a clear roadmap for efficient resource allocation.

My experience in biosecurity incident response spans over ten years, encompassing various roles from initial assessment and containment to full-scale investigation and remediation. I’ve managed incidents involving accidental release of biological agents, data breaches compromising sensitive research, and equipment malfunctions impacting biocontainment. My approach is always methodical and risk-based, prioritizing the immediate safety of personnel and the environment, followed by thorough investigation to determine the root cause, implement corrective actions, and prevent recurrence.

For example, during an incident involving a suspected contamination in a pharmaceutical cleanroom, I led a team in implementing a rapid containment strategy, including isolating the affected area, decontaminating equipment, and initiating thorough environmental sampling. We then launched a comprehensive investigation to identify the source of the contamination, and implemented new protocols and training to prevent future occurrences. This involved analyzing environmental monitoring data, reviewing Standard Operating Procedures (SOPs), and interviewing personnel. The outcome was improved biosecurity protocols, reinforced training, and a clear understanding of vulnerabilities within the cleanroom processes.

My understanding of biosecurity regulations in the pharmaceutical industry is extensive, encompassing GMP (Good Manufacturing Practices), GLP (Good Laboratory Practices), and GDP (Good Distribution Practices) guidelines alongside specific regulations like those from the FDA (Food and Drug Administration) and EMA (European Medicines Agency). These regulations emphasize the control of biological agents, including those used in manufacturing processes, minimizing risks of contamination, preventing the intentional or unintentional release of pathogens, and protecting the integrity of pharmaceutical products. I am well-versed in the requirements for personnel training, facility design and security, equipment maintenance and validation, and documentation procedures, all crucial components of a robust biosecurity system.

For instance, I’m intimately familiar with the requirements for the handling and disposal of hazardous biological materials, the need for robust access control systems, and the necessity of comprehensive environmental monitoring programs. Non-compliance in these areas can have severe consequences, including product recalls, regulatory penalties, and reputational damage. I always ensure my audits carefully scrutinize compliance with all applicable regulations.

Objectivity and impartiality are paramount in biosecurity audits. I ensure these principles are upheld through several key measures. Firstly, I follow a pre-defined audit scope and methodology, ensuring a consistent approach across all audits. This eliminates personal biases and promotes a standardized evaluation process. Secondly, I maintain a clear separation between my role as an auditor and any potential conflicts of interest, such as previous relationships with the audited organization. I declare any potential conflicts upfront and recuse myself if necessary. Thirdly, my audit reports are based on factual findings, supported by documented evidence and objective metrics, rather than personal opinions or assumptions.

Finally, I encourage open communication with all stakeholders throughout the audit process, fostering transparency and ensuring that all findings are clearly documented and explained. Peer review of audit reports is also utilized where appropriate, ensuring further checks and balances to maintain the integrity of the process. This multi-faceted approach guarantees that the audits are truly independent and unbiased.

During a biosecurity audit of a research facility, we discovered a significant lapse in the management of infectious agents. Specifically, we found that the facility’s inventory records for high-containment organisms were inaccurate and incomplete. This posed a substantial risk of accidental release or misidentification of samples, potentially leading to serious health consequences and operational disruptions.

Addressing this challenge required a multi-pronged approach. First, we collaborated with the facility to conduct a thorough inventory reconciliation, identifying missing, misplaced, or incorrectly documented samples. Second, we worked with the facility to implement improved inventory management software and revised Standard Operating Procedures (SOPs). This included training staff on proper record-keeping practices and enhancing the accountability of personnel for managing infectious materials. Third, we recommended and assisted with the implementation of enhanced physical security measures, improving access controls and storage conditions. The result was a considerably improved biosecurity posture and a more reliable inventory system for the research facility.

My familiarity with biosecurity technologies is extensive. I possess in-depth knowledge of various access control systems, ranging from simple card readers to sophisticated biometric authentication systems. I understand the implications of different access control levels and their role in restricting access to sensitive areas and materials. I am also proficient in assessing the effectiveness of video surveillance systems, including network cameras, analytics software, and recording infrastructure. This involves understanding how these systems can be used for real-time monitoring, incident investigation, and overall security enhancements.

Beyond this, I’m knowledgeable in other technologies such as environmental monitoring systems (detecting unauthorized entry or changes in environmental conditions), automated decontamination systems, and real-time location tracking of personnel and assets within high-security areas. Understanding the limitations and potential vulnerabilities of each technology is crucial for ensuring a layered, effective biosecurity approach. I often consider the integration of different technologies to create a comprehensive and robust security system.

Communicating biosecurity audit findings effectively requires tailoring the message to the specific audience. For senior management, the focus is on the overall risk assessment and the financial implications of identified vulnerabilities. For technical staff, the communication focuses on the specifics of identified gaps, recommending corrective actions, and providing technical guidance. For regulatory bodies, the focus should be on compliance with relevant regulations and the evidence demonstrating this compliance (or lack thereof).

I typically use a variety of communication methods, including formal reports, presentations, and interactive workshops. Visual aids, such as diagrams and charts, are utilized to enhance understanding. Furthermore, I always ensure there’s an opportunity for open dialogue and Q&A to address concerns and clarify any ambiguities. The goal is to ensure that all stakeholders understand the findings, their implications, and the recommended corrective actions, fostering a collaborative approach to enhancing biosecurity.

Key Performance Indicators (KPIs) for measuring biosecurity effectiveness vary based on the specific context, but generally include metrics related to incident rates, compliance levels, and the overall security posture. Examples include:

• Number of biosecurity incidents: This reflects the frequency of breaches or near misses.
• Time to containment: This measures the speed and efficiency of response to security incidents.
• Compliance with regulations and internal procedures: This tracks adherence to established rules and protocols.
• Effectiveness of security measures: This assesses the performance of various technologies and procedures.
• Staff training and competency: The level of knowledge and preparedness among personnel is crucial.
• Number and severity of security vulnerabilities identified during audits: This tracks progress in addressing weaknesses in the system.

By regularly monitoring these KPIs, organizations can gain insights into the effectiveness of their biosecurity program, identify areas for improvement, and demonstrate their commitment to protecting personnel, assets, and reputation.

Staying current in the dynamic field of biosecurity requires a multi-pronged approach. I regularly subscribe to and actively read publications from organizations like the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and relevant professional journals. These provide crucial updates on emerging threats and evolving best practices.

Furthermore, I actively participate in professional development activities, attending conferences, webinars, and workshops focused on biosecurity. Networking with other professionals in the field is invaluable, allowing for the exchange of information and insights on real-world challenges and solutions. This includes participating in online forums and professional societies dedicated to biosecurity. Finally, I regularly review and update my knowledge based on newly published research and government guidelines, ensuring my practices align with the latest scientific understanding and regulatory requirements.

My experience spans various sectors, providing me with a broad understanding of biosecurity challenges across diverse contexts. In agriculture, I’ve audited facilities for the prevention of the spread of plant and animal diseases, focusing on issues such as quarantine procedures, pest management, and biocontainment strategies. For example, I assessed a large poultry farm’s biosecurity protocols, identifying gaps in their disinfection procedures that could have led to avian influenza outbreaks.

Within the healthcare sector, I’ve conducted audits evaluating infection control practices, waste management protocols, and the secure handling of biological samples. A key area of focus is ensuring adherence to regulations surrounding the safe handling of hazardous materials. One memorable audit involved reviewing a hospital’s procedures for managing highly infectious pathogens, where I identified a critical weakness in their staff training program.

My work in the research sector has involved auditing laboratories handling biological agents, ensuring compliance with regulations like the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. This includes assessing risk assessments, safety protocols, and security measures to prevent unauthorized access or accidental release of potentially harmful materials. I once reviewed a research lab’s security system, recommending improvements to their access control system to mitigate potential theft of sensitive biological materials.

Dual-use research of concern (DURC) refers to biological research that could have both legitimate scientific benefits and potential misuse for malicious purposes, such as the development of biological weapons. This encompasses research involving pathogens, toxins, and other biological materials that could be easily weaponized. The concept is crucial because while advancing scientific knowledge is essential, we must mitigate the risk of such knowledge falling into the wrong hands.

A clear example is research on highly pathogenic viruses. While studying these viruses is crucial for developing treatments and vaccines, the same knowledge and techniques could be exploited to enhance the lethality of a biological weapon. Therefore, robust oversight and stringent biosecurity measures are necessary to manage the risks associated with DURC.

My understanding of DURC includes awareness of international guidelines and regulations aimed at minimizing these risks. This involves not only the physical security of labs and materials but also the responsible dissemination of research findings and the training of personnel on ethical considerations and security protocols.

Maintaining confidentiality is paramount in biosecurity audits. Before commencing an audit, I ensure that a clear confidentiality agreement is established with the auditee, outlining the scope of the audit, the handling of sensitive information, and the responsibilities of all parties involved. This agreement explicitly states that all information obtained during the audit is considered confidential and will not be disclosed to unauthorized individuals or organizations.

During the audit, I use secure methods for data collection and storage. Sensitive data is encrypted and stored on password-protected devices and systems. I strictly adhere to data protection regulations (e.g., HIPAA, GDPR) and organizational policies regarding data handling. Only authorized personnel have access to audit findings, and reports are carefully redacted to protect sensitive information not relevant to the audit objectives. After the audit, all documents and digital data related to the audit are securely destroyed or archived according to established retention policies.

Ethical considerations are central to biosecurity audits. The primary ethical concern is ensuring the integrity and objectivity of the audit process. This means remaining impartial and unbiased throughout the audit, avoiding conflicts of interest, and reporting findings accurately and transparently. It’s crucial to treat all individuals involved with respect and dignity, recognizing their contributions and expertise while addressing concerns professionally and constructively.

Another important ethical consideration is protecting the privacy and reputation of the auditee. Sensitive information uncovered during the audit must be handled with the utmost care, adhering to strict confidentiality protocols. Transparency in communicating findings and offering constructive suggestions for improvement is crucial for building trust and supporting positive change within the organization. Finally, maintaining professional boundaries and avoiding any actions that could be perceived as a conflict of interest are vital to upholding the integrity of the auditing process.

My experience includes applying various audit methodologies, adapting my approach based on the specific needs and context of each audit. I am proficient in using ISO standards, specifically ISO 31000 (Risk management) and ISO 27001 (Information security management), to assess an organization’s biosecurity risk management framework and its information security controls.

I also have experience using NIST frameworks, such as the NIST Cybersecurity Framework, which provides guidance on managing cybersecurity risks, including those related to biosecurity. This framework helps identify vulnerabilities and weaknesses, and provides strategies for enhancing an organization’s cyber resilience. In practice, I might use a combination of these methodologies, tailoring the audit process to address specific biosecurity risks identified in the organization’s operational context. This ensures that the audit is comprehensive and effective.

In some instances, a more tailored, bespoke methodology is needed. This is often the case when working with less regulated sectors or when evaluating unique biosecurity challenges, requiring careful consideration of specific organizational risks and regulatory landscape.

Disagreements can arise during audits, and handling them professionally is crucial for maintaining a constructive relationship with the auditee. My approach prioritizes open communication and collaborative problem-solving. The first step involves carefully reviewing the specific point of disagreement, ensuring a complete understanding of the auditee’s perspective.

I then attempt to clarify any misunderstandings by presenting clear evidence supporting my findings and patiently explaining the underlying rationale for my assessment. I always avoid accusatory language and focus on collaborative problem-solving. If the disagreement persists, I would document the issue in detail, including all supporting evidence and attempts to resolve the discrepancy. This documentation serves to provide a transparent record of the discussion. In rare instances where a resolution cannot be reached, I would escalate the issue to the appropriate level of management, ensuring a fair and impartial resolution process.

Throughout this process, maintaining a professional and respectful demeanor is essential, remembering that the goal is not to find fault but to improve biosecurity practices and minimize risks.

Assessing the effectiveness of employee biosecurity training goes beyond simply verifying attendance. It requires a multifaceted approach focusing on knowledge retention, behavioral changes, and overall impact on biosecurity practices.

• Knowledge Assessments: We utilize pre- and post-training quizzes, or even simulated scenarios, to measure knowledge gain. For example, a post-training quiz might include questions on proper decontamination procedures or recognizing suspicious activity. A significant improvement in scores demonstrates effective knowledge transfer.
• Behavioral Observation: Direct observation in the workplace is crucial. Are employees consistently adhering to protocols like hand hygiene, personal protective equipment (PPE) use, and waste disposal procedures? This can be achieved through regular workplace walkthroughs and documented observations.
• Incident Reporting and Analysis: A reduction in biosecurity incidents – such as accidental exposures, contamination events, or unauthorized access – directly reflects the success of training. Analyzing incident reports helps identify any training gaps or areas needing reinforcement.
• Feedback Mechanisms: Regular feedback surveys and focus groups provide valuable insights into employee understanding and perceptions of the training’s effectiveness. This helps tailor future training to address specific needs.

For instance, in a previous role, we implemented a new training program on handling infectious agents. By combining pre- and post-training assessments with observation checklists, we saw a 20% increase in correct PPE usage and a 15% decrease in reported contamination incidents within six months.

My experience in reviewing and evaluating biosecurity policies and procedures involves a systematic approach, ensuring alignment with best practices, regulatory requirements, and the specific operational context. This includes:

• Gap Analysis: I begin by thoroughly reviewing existing policies and procedures against relevant standards (e.g., WHO guidelines, national regulations). This identifies gaps in coverage, inconsistencies, or areas requiring improvement.
• Risk Assessment Integration: Policies must reflect a robust risk assessment, identifying vulnerabilities and outlining mitigation strategies. I ensure that procedures are designed to address identified risks effectively. For example, a risk assessment might highlight the potential for unauthorized access; the corresponding policy should clearly outline access control measures.
• Clarity and Accessibility: Policies should be clear, concise, and easily understandable for all personnel. I review for ambiguity, jargon, and ensure the policies are readily available and accessible to everyone who needs them.
• Practicality and Feasibility: Policies and procedures must be practical and feasible to implement within the organizational context. Unrealistic expectations can lead to non-compliance. I assess the practicality of implementing procedures and suggest modifications if needed.
• Documentation and Record Keeping: I evaluate the effectiveness of record-keeping procedures, ensuring that all necessary information is documented accurately and securely.

In a recent review, I identified a critical gap in a laboratory’s access control policy. This gap, if left unaddressed, could have jeopardized the safety of personnel and the integrity of research materials. By implementing a multi-factor authentication system, we successfully mitigated this vulnerability.

Data analytics plays a crucial role in enhancing biosecurity by providing insights that support proactive risk management and improved decision-making. My experience includes using data analytics to:

• Identify Patterns and Trends: Analyzing data from various sources – such as access logs, incident reports, and environmental monitoring – can reveal patterns and trends that might indicate vulnerabilities or emerging risks. For example, repeated unauthorized access attempts from a specific IP address might signal a security breach.
• Optimize Resource Allocation: Data analytics can help determine where to focus biosecurity resources most effectively. By analyzing risk probabilities and potential impacts, we can prioritize areas needing immediate attention and allocate resources accordingly.
• Monitor Effectiveness of Controls: Analyzing data related to implemented biosecurity controls (e.g., number of successful logins, frequency of equipment maintenance) helps assess their effectiveness and identify areas for improvement. A decline in successful login attempts after implementing a new access control system indicates its success.
• Predictive Modeling: Advanced analytics can be used to build predictive models that anticipate potential biosecurity threats. This allows for proactive mitigation strategies. For example, analyzing weather patterns and historical data on disease outbreaks can help predict potential pandemic risks.

In one instance, I utilized data analytics to identify a previously unrecognized pattern of unauthorized access to a high-security area, leading to the implementation of enhanced surveillance and access control measures.

Ensuring audit efficiency and cost-effectiveness requires a well-planned and targeted approach. Key strategies include:

• Scope Definition: Clearly defining the audit scope, focusing on high-risk areas, prevents unnecessary work and keeps costs down. A detailed risk assessment helps determine which areas require the most scrutiny.
• Risk-Based Sampling: Rather than conducting exhaustive checks everywhere, employing risk-based sampling allows for a more targeted approach, focusing on areas with the highest probability of risks.
• Automation: Automating tasks like data collection and analysis using specialized biosecurity software significantly reduces manual effort and increases efficiency. This also minimizes human error.
• Effective Communication: Maintaining clear communication with auditees throughout the process facilitates a smoother and more collaborative audit, minimizing delays and potential conflicts.
• Standardized Procedures: Implementing standardized audit procedures ensures consistency and allows for faster and more accurate assessment, reducing costs in the long run.

For example, by using automated data extraction tools to analyze access logs, we reduced audit time by 40% in a recent project. This allowed for more time to be dedicated to higher-level analysis and recommendations.

My proficiency in biosecurity-related software and tools is extensive. I am experienced with various types of software, including:

• Access Control Systems: I have experience working with various access control systems, both physical (e.g., card readers, biometric scanners) and digital (e.g., multi-factor authentication systems). This includes configuring, managing, and auditing these systems.
• Security Information and Event Management (SIEM) Systems: I am proficient in using SIEM systems to collect, analyze, and monitor security-related events, identifying potential threats and vulnerabilities in real-time.
• Data Analytics Platforms: I am experienced in using data analytics platforms (e.g., Tableau, Power BI) to analyze biosecurity data, identify trends, and create reports.
• Laboratory Information Management Systems (LIMS): Experience with LIMS allows for effective auditing of sample tracking, testing procedures, and data management within laboratories.
• Specialized Biosecurity Software: I have experience with specialized software for tasks such as risk assessment, vulnerability management, and incident management.

I am adept at utilizing these tools to enhance the efficiency and effectiveness of biosecurity audits, generating comprehensive reports, and providing actionable insights.

My career goals involve becoming a recognized leader in the field of biosecurity auditing. This includes:

• Advanced Training and Certification: I plan to pursue advanced certifications in relevant areas such as information security and risk management to further enhance my expertise.
• Leadership Roles: I aspire to take on leadership roles in biosecurity audit teams, mentoring junior auditors and shaping the direction of audit practices within organizations.
• Industry Collaboration: I aim to actively participate in professional organizations and collaborate with industry experts to share knowledge and contribute to the advancement of biosecurity practices.
• Research and Publication: I’m interested in conducting research on emerging biosecurity challenges and publishing my findings to contribute to the body of knowledge in this field.
• Global Impact: Ultimately, I want to contribute to improving biosecurity practices globally, helping organizations protect against biological threats and safeguard public health.

My passion for biosecurity stems from a desire to protect people and critical infrastructure from biological threats, and I believe a strong audit function is essential for achieving this.